Corcept Therapeutics
CORT
#2248
Rank
S$11.07 B
Marketcap
S$103.14
Share price
-2.25%
Change (1 day)
11.69%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of March 2026 : S$12.43 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is S$12.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$7.84 M-16.83%
2024-12-31S$9.42 M4627.52%
2023-12-31S$0.19 M-86.99%
2022-12-31S$1.53 M115.48%
2021-12-31S$0.71 M-78.93%
2020-12-31S$3.37 M-27.67%
2019-12-31S$4.66 M
2018-12-31N/A
2016-12-31S$21.22 M0.26%
2015-12-31S$21.16 M70%
2014-12-31S$12.45 M71.14%
2013-12-31S$7.27 M124.53%
2012-12-31S$3.24 M
2010-12-31N/A-100%
2009-12-31S$0 M-63.19%
2008-12-31S$0.02 M-45.17%
2007-12-31S$0.04 M-35.2%
2006-12-31S$0.06 M-28.37%
2005-12-31S$0.08 M
2003-12-31S$0.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$70.97 B 570,482.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$60.66 B 487,582.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$82.26 B 661,205.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.98 B 449,936.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$63.39 B 509,571.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$59.92 B 481,668.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.42 B 3,334.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.39 B 3,083.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.85 B 14,838.26%๐Ÿ‡บ๐Ÿ‡ธ USA